Insider trading

Period: 120 months Stock: DTIL Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

78 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

78 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

78 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

78 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
78 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
78 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

78 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Sep 2026
Frankel Stanley Director
Bought
$6.00K 1,000 at 6.00
2.5%
Cluster · 3 buyers
25 Sep 2026
Germano Geno J Director
Bought
$16.38K 2,609 at 6.28
5.8%
Cluster · 3 buyers
25 Sep 2026
Brown Melinda Director
Bought
$7.12K 1,135 at 6.27
2.6%
Cluster · 3 buyers
16 Dec 2025
Germano Geno J Director
Bought
$14.16K 3,000 at 4.72
14.4%
Cluster · 3 buyers
16 Dec 2025
Frankel Stanley Director
Bought
$12.69K 2,700 at 4.70
16.1%
Cluster · 3 buyers
15 Dec 2025
Brown Melinda Director
Bought
$6.86K 1,381 at 4.97
6.3%
Cluster · 3 buyers
26 Sep 2025
Frankel Stanley Director
Bought
$13.42K 2,700 at 4.97
19.2%
Cluster · 3 buyers
22 Sep 2025
Brown Melinda Director
Bought
$6.85K 1,400 at 4.89
6.8%
Cluster · 3 buyers
25 Jun 2025
Buehler Kevin Director
Bought
$21.12K 5,076 at 4.16
22.0%
Cluster · 3 buyers
25 Jun 2025
Brown Melinda Director
Bought
$6.96K 1,682 at 4.14
8.9%
Cluster · 3 buyers
26 Mar 2025
Buehler Kevin Director
Bought
$21.12K 4,523 at 4.67
51.9%
Cluster · 3 buyers
26 Mar 2025
Brown Melinda Director
Bought
$8.74K 1,839 at 4.75
25.5%
Cluster · 3 buyers
25 Mar 2025
Germano Geno J Director
Bought
$17.23K 3,250 at 5.30
41.6%
Cluster · 3 buyers
30 Dec 2024
Germano Geno J Director
Bought
$16.19K 3,605 at 4.49
85.8%
Cluster · 3 buyers
27 Dec 2024
Buehler Kevin Director
Bought
$21.08K 4,320 at 4.88
98.4%
Cluster · 3 buyers
27 Dec 2024
Kelly John Alexander Chief Financial Officer
Bought
$10.04K 2,113 at 4.75
5.5%
Cluster · 3 buyers
26 Dec 2024
Brown Melinda Director
Bought
$13.72K 3,016 at 4.55
71.8%
Cluster · 3 buyers
21 Nov 2024
Kelly John Alexander Chief Financial Officer
Bought
$20.28K 3,000 at 6.76
8.6%
Cluster · 3 buyers
4 Nov 2024
Amoroso Michael President and CEO
Sold at will
$24.67K 3,012 at 8.19
9.5%
Not planned
10 Jun 2024
SMITH J. JEFFERSON Chief Research Officer
Sold at will
$589.50 50 at 11.79
0.1%
Not planned
2 May 2024
Amoroso Michael President and CEO
Sold at will
$15.75K 1,526 at 10.32
10.0%
Not planned
2 May 2024
List Alan Chief Medical Officer
Sold at will
$2.99K 290 at 10.32
6.1%
Not planned
2 May 2024
SMITH J. JEFFERSON Chief Research Officer
Sold at will
$1.59K 154 at 10.32
0.2%
Not planned
30 Apr 2024
List Alan Chief Medical Officer
Sold at will
$2.39K 238 at 10.03
5.9%
Not planned
23 Jan 2024
SMITH J. JEFFERSON Chief Research Officer
Sold at will
$10.36K 28,000 at 0.37
1.4%
Not planned
17 Mar 2023
Kelly John Alexander Chief Financial Officer
Bought
$17.20K 20,000 at 0.86
8.9%
Cluster · 3 buyers
6 Mar 2023
Scimeca Dario General Counsel and Secretary
Sold, plan not stated
$13.02K 12,172 at 1.07
19.6%
6 Mar 2023
List Alan Chief Medical Officer
Sold, plan not stated
$10.14K 9,473 at 1.07
19.9%
17 Oct 2022
Amoroso Michael President and CEO
Sold, plan not stated
$14.53K 11,006 at 1.32
45.5%
23 Sep 2022
Kelly John Alexander Chief Financial Officer
Bought
$10.09K 8,200 at 1.23
5.3%
Cluster · 3 buyers
22 Sep 2022
Kelly John Alexander Chief Financial Officer
Bought
$49.63K 37,037 at 1.34
31.5%
Cluster · 3 buyers
22 Jun 2022
Kelly John Alexander Chief Financial Officer
Bought
$50.68K 33,784 at 1.50
40.3%
Cluster · 3 buyers
8 Jun 2022
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$38.83K 18,849 at 2.06
0.5%
8 Jun 2022
Scimeca Dario General Counsel and Secretary
Sold, plan not stated
$20.26K 9,833 at 2.06
23.2%
27 Apr 2022
List Alan Chief Medical Officer
Sold, plan not stated
$16.33K 7,775 at 2.10
29.9%
17 Mar 2022
Kelly John Alexander Chief Financial Officer
Bought
$51.37K 16,677 at 3.08
85.5%
Cluster · 3 buyers
23 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$319.50K 30,000 at 10.65
21.2%
21 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$161.55K 15,000 at 10.77
11.9%
18 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$110.00K 10,000 at 11.00
8.2%
17 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$104.40K 10,000 at 10.44
8.2%
15 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$32.01K 2,858 at 11.20
2.5%
11 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$345.60K 30,000 at 11.52
21.2%
17 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$187.60K 20,000 at 9.38
0.5%
14 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$88.70K 9,673 at 9.17
0.2%
13 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$88.51K 9,673 at 9.15
0.2%
13 May 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$86.69K 9,675 at 8.96
0.5%
12 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$84.37K 9,676 at 8.72
0.2%
10 May 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$80.40K 9,746 at 8.25
0.5%
7 May 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$83.49K 9,742 at 8.57
0.5%
19 Apr 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$84.08K 9,676 at 8.69
0.2%
Showing 1–50 of 78. Page 1 of 2 Older →